Data as of Jul 28
| -0.18 / -1.87%|
The 4 analysts offering 12-month price forecasts for Derma Sciences Inc have a median target of 18.50, with a high estimate of 19.00 and a low estimate of 16.00. The median estimate represents a +95.77% increase from the last price of 9.45.
The current consensus among 5 polled investment analysts is to Buy stock in Derma Sciences Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.